Literature DB >> 10528569

A dental-based, athletic trainer-mediated spit tobacco cessation program for professional baseball players.

M M Walsh1, J C Greene, J A Ellison, M A Letendre, N Bergert.   

Abstract

During 1997 spring training, the National Spit Tobacco Education Program provided a spit (smokeless) tobacco intervention program to 16 professional baseball clubs. The program consisted of an awareness-raising presentation and an opportunity to discuss quitting spit tobacco use with an expert cessation counselor. For two clubs, however, a more extensive intervention was pilot-tested for feasibility and acceptability among their major- and minor-league teams during their regularly scheduled health examinations at the beginning of spring training. The intervention included an oral exam by a dentist who advised spit tobacco users to stop and pointed out any spit tobacco-associated lesions in the player's mouth, brief cessation counseling by a specially trained dental hygienist, and ongoing support and follow-up by the certified athletic trainer to promote cessation. Findings from this pilot study indicate that this intervention, which is dependent upon involvement of dental professionals, was feasible to implement during spring training and appeared to be well-received by the athletes. Dental professionals are in an excellent position to advise and help spit tobacco users to quit and can have an important role in helping youth overcome this rapidly growing addiction.

Entities:  

Mesh:

Year:  1998        PMID: 10528569

Source DB:  PubMed          Journal:  J Calif Dent Assoc        ISSN: 1043-2256


  2 in total

1.  Smokeless tobacco use among professional baseball players: survey results, 1998 to 2003.

Authors:  H H Severson; K Klein; E Lichtensein; N Kaufman; C T Orleans
Journal:  Tob Control       Date:  2005-02       Impact factor: 7.552

2.  Smokeless tobacco cessation interventions: A systematic review.

Authors:  Suzanne Tanya Nethan; Dhirendra Narain Sinha; Kumar Chandan; Ravi Mehrotra
Journal:  Indian J Med Res       Date:  2018-10       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.